StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30147% above fair value
$55.75−0.60 (-1.06%)

Close on Nov 20, 2026Market cap $3.33BP/E –Yield –

Axogen gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Axogen's gross profit for the twelve months ending Sep 30, 2026 was $198.00M, up 23.4% year over year. For fiscal 2025 it was $167.35M, up 17.9% from the year before. Over ten years it grew 22.2% a year on average. The highest annual figure on record is $167.35M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$167.35M+17.9%
FY2024Dec 31, 2024$141.98M+16.5%
FY2023Dec 31, 2023$121.87M+12.0%
FY2022Dec 31, 2022$108.81M+4.2%
FY2021Dec 31, 2021$104.43M+15.1%
FY2020Dec 31, 2020$90.72M+1.5%
FY2019Dec 31, 2019$89.36M+25.8%
FY2018Dec 31, 2018$71.01M+38.9%
FY2017Dec 31, 2017$51.12M+47.6%
FY2016Dec 31, 2016$34.64M+54.1%
FY2015Dec 31, 2015$22.48M+68.1%
FY2014Dec 31, 2014$13.38M+57.2%
FY2013Dec 31, 2013$8.51M+48.5%
FY2012Dec 31, 2012$5.73M+136.5%
FY2011Dec 31, 2011$2.42M+49.1%
FY2010Dec 31, 2010$1.63M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$56.73M+23.3%
Q2 FY2026Jun 30, 2026$50.67M+20.6%
Q1 FY2026Mar 31, 2026$46.19M+32.2%
Q4 FY2025Dec 31, 2025$44.41M+18.2%
Q3 FY2025Sep 30, 2025$45.99M+26.2%
Q2 FY2025Jun 30, 2025$42.02M+18.9%
Q1 FY2025Mar 31, 2025$34.93M+7.1%
Q4 FY2024Dec 31, 2024$37.58M+17.3%
Q3 FY2024Sep 30, 2024$36.44M+14.9%
Q2 FY2024Jun 30, 2024$35.35M+19.2%
Q1 FY2024Mar 31, 2024$32.62M+14.5%
Q4 FY2023Dec 31, 2023$32.02M+31.3%
Q3 FY2023Sep 30, 2023$31.70M+3.0%
Q2 FY2023Jun 30, 2023$29.65M+5.3%
Q1 FY2023Mar 31, 2023$28.49M+11.9%
Q4 FY2022Dec 31, 2022$24.40M-6.6%
Q3 FY2022Sep 30, 2022$30.78M+18.6%
Q2 FY2022Jun 30, 2022$28.17M+6.4%
Q1 FY2022Mar 31, 2022$25.46M-1.6%
Q4 FY2021Dec 31, 2021$26.11M-3.4%
Q3 FY2021Sep 30, 2021$25.97M-6.4%
Q2 FY2021Jun 30, 2021$26.49M+60.4%
Q1 FY2021Mar 31, 2021$25.87M+33.0%
Q4 FY2020Dec 31, 2020$27.03M+16.1%
Q3 FY2020Sep 30, 2020$27.73M+15.3%
Q2 FY2020Jun 30, 2020$16.51M-26.5%
Q1 FY2020Mar 31, 2020$19.45M-0.6%
Q4 FY2019Dec 31, 2019$23.28M+17.6%
Q3 FY2019Sep 30, 2019$24.05M+25.3%
Q2 FY2019Jun 30, 2019$22.46M+28.5%
Q1 FY2019Mar 31, 2019$19.57M+34.5%
Q4 FY2018Dec 31, 2018$19.79M+37.9%
Q3 FY2018Sep 30, 2018$19.20M+41.8%
Q2 FY2018Jun 30, 2018$17.48M+35.6%
Q1 FY2018Mar 31, 2018$14.55M+40.9%
Q4 FY2017Dec 31, 2017$14.36M+49.9%
Q3 FY2017Sep 30, 2017$13.54M–
Q2 FY2017Jun 30, 2017$12.89M–
Q1 FY2017Mar 31, 2017$10.33M–
Q4 FY2016Dec 31, 2016$9.58M–

More Axogen figures

See a number that looks wrong?